Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

KIR/HLA ligands immunogenetics markers associated with outcome of hepatitis B virus infection in the Bulgarian population

V. Varbanova, G. Popov, V. Grigorova, D. Petrova, E. Naumova, A. Mihaylova

. 2021 ; 165 (3) : 270-276. [pub] 20200921

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22005982

BACKGROUND: Hepatitis B virus (HBV) infection is one of the most common infections worldwide, having negative impact on world health due to the tendency for chronification with late complications such as liver cirrhosis and hepatocellular carcinoma. Natural killer (NK) cells as part of innate antiviral defense influence the clinical course of HBV infection: elimination of the virus or chronic disease. AIM: Therefore, we investigated the polymorphisms of the main gene systems, regulating NK-cell function: killer cell immunoglobulin-like receptors (KIRs) and their appropriate HLA class I ligands in 144 HBV infected patients (124 chronic carriers and 20 spontaneously recoved) and 126 ethnically matched healthy controls from the Bulgarian population in a case-control study. METHODS: KIRs and HLA ligands were determined by PCR-SSP or PCR high-resolution typing methods. RESULTS: KIR2DL5B allele variant was significantly less frequent in spontaneously recovered (SR) patients compared to healthy controls (10.0% vs. 45.5%, Pcorr=0.006). The presence of KIR3DL1*004 allele was higher in chronic HBV carriers (CH) than in controls (33.1% vs. 17.6%, Pcorr=0.036). Additionally, SR patients differed from healthy individuals by the lower frequency of HLA-Bw4Ile80 group ligands (30.0% vs 63.7%, P=0.015). Three KIR genotypes were found more frequent in healthy in comparison with HBV infected individuals: ID2 (13.5% vs 5.6%, P=0.025), KIR genotype containing 6 activating KIRs (18.0% vs 7.6%, P=0.017), and KIR genotype composed of 4 activating and 5 inhibitory KIRs (23.8% vs 5.6%, P=0.001). CONCLUSION: These data suggest that inherited KIR and HLA class I ligand polymorphisms may influence the clinical course of HBV infection.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc22005982
003      
CZ-PrNML
005      
20220224154631.0
007      
ta
008      
220207s2021 xr f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2020.043 $2 doi
035    __
$a (PubMed)32975242
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Varbanova, Viktoria $u Clinic of Hematology, Military Medical Academy, MHAT, Sofia, Bulgaria
245    10
$a KIR/HLA ligands immunogenetics markers associated with outcome of hepatitis B virus infection in the Bulgarian population / $c V. Varbanova, G. Popov, V. Grigorova, D. Petrova, E. Naumova, A. Mihaylova
504    __
$a Literatura
520    9_
$a BACKGROUND: Hepatitis B virus (HBV) infection is one of the most common infections worldwide, having negative impact on world health due to the tendency for chronification with late complications such as liver cirrhosis and hepatocellular carcinoma. Natural killer (NK) cells as part of innate antiviral defense influence the clinical course of HBV infection: elimination of the virus or chronic disease. AIM: Therefore, we investigated the polymorphisms of the main gene systems, regulating NK-cell function: killer cell immunoglobulin-like receptors (KIRs) and their appropriate HLA class I ligands in 144 HBV infected patients (124 chronic carriers and 20 spontaneously recoved) and 126 ethnically matched healthy controls from the Bulgarian population in a case-control study. METHODS: KIRs and HLA ligands were determined by PCR-SSP or PCR high-resolution typing methods. RESULTS: KIR2DL5B allele variant was significantly less frequent in spontaneously recovered (SR) patients compared to healthy controls (10.0% vs. 45.5%, Pcorr=0.006). The presence of KIR3DL1*004 allele was higher in chronic HBV carriers (CH) than in controls (33.1% vs. 17.6%, Pcorr=0.036). Additionally, SR patients differed from healthy individuals by the lower frequency of HLA-Bw4Ile80 group ligands (30.0% vs 63.7%, P=0.015). Three KIR genotypes were found more frequent in healthy in comparison with HBV infected individuals: ID2 (13.5% vs 5.6%, P=0.025), KIR genotype containing 6 activating KIRs (18.0% vs 7.6%, P=0.017), and KIR genotype composed of 4 activating and 5 inhibitory KIRs (23.8% vs 5.6%, P=0.001). CONCLUSION: These data suggest that inherited KIR and HLA class I ligand polymorphisms may influence the clinical course of HBV infection.
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a genotyp $7 D005838
650    12
$a hepatitida B $x genetika $7 D006509
650    _2
$a virus hepatitidy B $x genetika $7 D006515
650    _2
$a lidé $7 D006801
650    _2
$a imunogenetika $7 D007125
650    _2
$a ligandy $7 D008024
650    12
$a nádory jater $7 D008113
650    _2
$a receptory KIR $x genetika $7 D054340
650    _2
$a receptory KIR2DL5 $7 D054346
655    _2
$a časopisecké články $7 D016428
700    1_
$a Popov, Georgi $u Clinic of Infection Diseases, Military Medical Academy, MHAT, Sofia, Bulgaria
700    1_
$a Grigorova, Veneta $u Department of Cardiac Surgery, Acibadem City Clinic, Tokuda Hospital, Sofia, Bulgaria
700    1_
$a Petrova, Diana $u Clinic of Propaedeutics in Internal Diseases, University Hospital "Alexandrovska", Medical University, Sofia, Bulgaria
700    1_
$a Naumova, Elissaveta $u Clinic of Clinical Immunology and Stem Cell Bank, University Hospital "Alexandrovska", Medical University, Sofia, Bulgaria
700    1_
$a Mihaylova, Anastasiya $u Clinic of Clinical Immunology and Stem Cell Bank, University Hospital "Alexandrovska", Medical University, Sofia, Bulgaria
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 165, č. 3 (2021), s. 270-276
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32975242 $y Pubmed
910    __
$a ABA008 $b A 1502 $c A 1502 $y p $z 0
990    __
$a 20220207 $b ABA008
991    __
$a 20220224154618 $b ABA008
999    __
$a ok $b bmc $g 1763632 $s 1157135
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 165 $c 3 $d 270-276 $e 20200921 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20220207

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace